- Tytuł:
- Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
- Autorzy:
- Źródło:
- In The Lancet Oncology July 2021 22(7):946-958
Czasopismo naukowe